logo

Cellectar Biosciences Inc (CLRB)



Trade CLRB now with
  Date
  Headline
9/22/2021 8:58:12 AM CLRB : Iopofosine I-131- External Beam Radiation Data Suggests Safety And Tolerability InRefractory Head And Neck Cancer
8/18/2021 8:33:15 AM Cellectar Granted $2 Mln Phase II NIH SBIR Grant To Support Study Of Iopofosine I-131 In Waldenstrom’s Macroglobulinemia
7/12/2021 8:35:31 AM Cellectar Announces Co-Development And Commercialization Collaboration With LegoChemBio
1/27/2021 8:42:44 AM Cellectar Gets Orphan Drug Designation From EMA For CLR 131 In Waldenstrom's Macroglobulinemia